Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

R James Meyers


  • Director at Cytomx Therapeutics Inc. (CTMX), 2020-06-19
  • Director at Sangamo Therapeutics Inc (SGMO), 2020-06-03
  • Director at Arbutus Biopharma Corp (ABUS), 2020-06-01
  • Evp Worldwide Commercial Ops at Gilead Sciences Inc (GILD), 2018-02-23
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GILD $80.99 24,843 Officer 2,715 2018-01-16 Filing
GILD $80.00 75,157 Officer 27,558 2018-01-16 Filing
GILD $83.64 16,700 Officer 2,715 2017-08-31 Filing
GILD $83.01 43,300 Officer 19,415 2017-08-31 Filing